Ventricular assist devices (VADs) have been placed as destination therapy in adults for more than 20 years, but have only recently been considered an option in a subset of pediatric patients. A 2016 report from the Pediatric Interagency Registry for Mechanical Circulatory Support revealed only eight pediatric patients implanted with a VAD as destination therapy. Herein, we report the case of an adolescent male with Becker muscular dystrophy who underwent VAD placement in 2011 as bridge to candidacy. He subsequently decided to remain as destination therapy and so far has accrued more than 2100 days on VAD support, the longest duration of pediatric VAD support reported in the literature to date.
From the *Division of Pediatric Cardiology, Stanford University, Palo Alto, California; †Lucile Packard Children’s Hospital, Palo Alto, California; and ‡Department of Cardiothoracic Surgery, Stanford University, Palo Alto, California.
Disclosure: The authors have no conflicts of interest to report.
Correspondence: Neha J. Purkey, The Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, 725 Welch Road, Palo Alto, CA 94304. Email: firstname.lastname@example.org.